First In Human Study of CX-801 in Advanced Solid Tumors

Clinical trial NCT06462794 · RECRUITING

Trial details

NCT number: NCT06462794
Sponsor: CytomX Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2024-08-28
Primary completion: 2028-02-28
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.